senckađ
Group745
Group745
Group745
Group745
Group745
Group745

Leo Pharma - Adtralza Patient Support

Leo Pharma
13/06/2022
Advertising Agency
London, UK
28
Share
Credits

Insight
LEO Pharma has over 110 years of expertise in developing innovative care solutions and holistic programmes.

Worldwide, an estimated 20% of children and 3% of the adult population are affected by eczema. Many follow treatment plans which can be challenging to adhere to, including administrating Adtralza via injection to reduce inflammation and improve skin condition.

Idea
An experience designed around patients’ daily life.

The My LEO Pharma app gives guidance and support to succeed with treatment. It advises people when and how to administer medication and enables rashes, stress, sleep and nutrition to be tracked.

The journal allows patients to keep track of treatment progress which can be shared with doctors. The app also enables photos of skin texture to be captured and documented for later comparison.

The data visualises patterns in the patient’s lifestyle on a simple timeline so that the overview of the road to healthier skin becomes clear and straightforward.


Impact
Daily adherence boosted.

Launched in line with a new Adtralza® product in Germany, the free app has been downloaded by almost all patients who are now using it daily. Based on this success, the app is being updated with new services and will be introduced in more countries.

About AKQA UK

AKQA is a design and innovation company that employs over 6,500 professionals across 20 countries. Named Digital Agency Global Network of the Year in Campaign’s 2023 Global Agency of the Year Awards, AKQA was also awarded the Cannes Lions Grand Prix for Digital Craft in 2023, and the Grand Prix for Design in 2021. In 2023, AKQA was recognised as a winner in Fast Company’s Innovation by Design Awards. AKQA also won Fast Company’s World Changing Ideas in 2021, and 2022 and led Gartner’s research into global marketing agencies in 2021.